224 related articles for article (PubMed ID: 3922077)
1. The application of a monoclonal antibody to factor VIII related antigen (VIIIRAg) in immunoradiometric assays for factor VIII.
Thomas JE; Peake IR; Giddings JC; Welch AN; Bloom AL
Thromb Haemost; 1985 Feb; 53(1):143-7. PubMed ID: 3922077
[TBL] [Abstract][Full Text] [Related]
2. An immunoradiometric assay for factor VIII related antigen (VIIIRAg) using two monoclonal antibodies-comparison with polyclonal rabbit antibodies for use in von Willebrand's disease diagnosis.
Sultan Y; Avner P; Maisonneuve P; Arnaud D; Jeanneau C
Thromb Haemost; 1984 Dec; 52(3):250-2. PubMed ID: 6442468
[TBL] [Abstract][Full Text] [Related]
3. Using a monoclonal antibody to identify patients with type I and type II von Willebrand's disease.
Hall JD; Willis DW; Evatt BL; Jackson DW
Thromb Haemost; 1987 Jun; 57(3):332-6. PubMed ID: 3116703
[TBL] [Abstract][Full Text] [Related]
4. Immunoradiometric measurement of the factor VIII procoagulant antigen.
Lazarchick J; Hoyer LW
J Clin Invest; 1978 Nov; 62(5):1048-52. PubMed ID: 81838
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
[TBL] [Abstract][Full Text] [Related]
6. A critical evaluation of the available methods for the determination of factor VIII von Willebrand.
Casonato A; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):670-84. PubMed ID: 2435633
[TBL] [Abstract][Full Text] [Related]
7. An immunoradiometric assay for human factor VIII/von Willebrand factor (VIII:vWF) using a monoclonal antibody that defines a functional epitope.
Goodall AH; Jarvis J; Chand S; Rawlings E; O'Brien DP; McGraw A; Hutton R; Tuddenham EG
Br J Haematol; 1985 Apr; 59(4):565-77. PubMed ID: 2580547
[TBL] [Abstract][Full Text] [Related]
8. The use of monoclonal antibodies in measuring factor VIII/von Willebrand factor.
Lamme S; Wallmark A; Holmberg L; Nilsson IM; Sjögren HO
Scand J Clin Lab Invest; 1985 Feb; 45(1):17-26. PubMed ID: 3919440
[TBL] [Abstract][Full Text] [Related]
9. Differences between heterozygous dominant and recessive von Willebrand's disease type I expressed by bleeding symptoms and combinations of factor VIII variables.
Wahlberg TB; Blombäck M; Ruggeri ZM
Thromb Haemost; 1983 Dec; 50(4):864-8. PubMed ID: 6420925
[TBL] [Abstract][Full Text] [Related]
10. Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder.
Joist JH; Cowan JF; Zimmerman TS
N Engl J Med; 1978 May; 298(18):988-91. PubMed ID: 306064
[TBL] [Abstract][Full Text] [Related]
11. A two-site, monoclonal antibody-based immunoassay for von Willebrand factor--demonstration that vWF function resides in a conformational epitope.
Chand S; McCraw A; Hutton R; Tuddenham EG; Goodall AH
Thromb Haemost; 1986 Jun; 55(3):318-24. PubMed ID: 2428124
[TBL] [Abstract][Full Text] [Related]
12. A rapid one-step immunoradiometric assay for factor VIII-procoagulant antigen utilizing monoclonal antibodies.
Stel HV; Veerman EC; Huisman JG; Janssen MC; van Mourik JA
Thromb Haemost; 1983 Dec; 50(4):860-3. PubMed ID: 6420924
[TBL] [Abstract][Full Text] [Related]
13. The combined use of monoclonal antibody-based enzyme-linked immunosorbent assays (ELISA) for factor VIII antigen (VIII:Ag) and von Willebrand factor antigen (vWF:Ag) for the detection of carriers of haemophilia A.
Furlong RA; Chesham J; Peake IR
Clin Lab Haematol; 1988; 10(3):295-305. PubMed ID: 3141105
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies against the human factor VIII von Willebrand molecule: characterization and potential for screening of von Willebrand patients.
Avner P; Arnaud D; Sultan Y; Maisonneuve P; Jeanneau C
Dev Biol Stand; 1984; 57():69-76. PubMed ID: 6084622
[TBL] [Abstract][Full Text] [Related]
15. [Enzyme-linked immunoabsorbent assay of factor VIII-related antigen. Interest in study of Von Willerbrand's disease (author's transl)].
Mazurier C; Parquet-Gernez A; Goudemand M
Pathol Biol (Paris); 1977 Dec; 25 Suppl():18-24. PubMed ID: 353655
[TBL] [Abstract][Full Text] [Related]
16. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
Chediak J; Peake I; Bloom A
Thromb Haemost; 1983 Aug; 50(2):509-12. PubMed ID: 6415844
[TBL] [Abstract][Full Text] [Related]
17. The factor VIII abnormality in severe von Willebrand's disease.
Zimmerman TS; Abildgaard CF; Meyer D
N Engl J Med; 1979 Dec; 301(24):1307-10. PubMed ID: 315519
[TBL] [Abstract][Full Text] [Related]
18. Reactivity of small molecular forms of human factor VIII/von Willebrand factor with botrocetin and anti-factor VIII-coated latex particles.
Furlan M; Perret BA; Beck EA
Thromb Haemost; 1985 Aug; 54(2):463-5. PubMed ID: 3936216
[TBL] [Abstract][Full Text] [Related]
19. Abnormal antigenic reactivity of factor VIII/von Willebrand factor subunit in variants of von Willebrand's disease.
Girma JP; Pietu G; Lavergne JM; Meyer D; Larrieu MJ
J Lab Clin Med; 1982 Apr; 99(4):481-94. PubMed ID: 6174657
[TBL] [Abstract][Full Text] [Related]
20. Factor VIII competitive enzyme assay: observations in von Willebrand's variants and hemophiliacs.
Yorde LD; Yorde DE; Sasse EA; Hussey CV
Clin Physiol Biochem; 1984; 2(6):298-303. PubMed ID: 6440727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
